Discover how precision lung cancer care tackles gene fusions, new HER2/ROS1/ALK drugs, expanded screening, and liquid ...

CHICAGO -- SGLT2 inhibitor use was linked to reduced progression of in-situ pulmonary adenocarcinoma, an observational study showed. Nodule growth over the median 28 months of follow-up was 62% less ...

The American Cancer Society’s Cancer Statistics, 2026 report highlights a historic milestone: the 5-year relative survival ...

(PTx) announced findings from a post hoc analysis of the eNRGy trial (NCT02912949) evaluating treatment beyond progression with zenocutuzumab in patients with advanced neuregulin 1 fusion-positive ...

Spatial maps of lung precancer and cancer cells at different points in development advance understanding of the earliest stages of lung cancer Findings highlight inflammation as a driver of lung tumor ...

Please provide your email address to receive an email when new articles are posted on . In this video, Charu Aggarwal, MD, MPH, the Leslye M. Heisler Professor for Lung Cancer Excellence at University ...

In the United States and elsewhere, there’s been a major shift in patients treated for lung cancer. As the percentage of people who smoke has declined over the decades, people who’ve never smoked have ...

Squamous cell carcinoma of the lung is linked to smoking and requires early detection and accurate staging for effective treatment. Diagnosis involves imaging and biopsy, with the TNM system used to ...

Lung cancer was the most commonly occurring cancer worldwide in 2022. It accounted for 2.5 million new cases which is 12.4% of the total new cases.

Add Yahoo as a preferred source to see more of our stories on Google. MIDLAND, Texas (KMID/KPEJ)- The Texas Medical Association reported fewer cases of lung cancer across Texas in 2025. “What we’ve ...